185 results

• Onglyza Risks Lead Express Scripts to Drop Drug from 2016 Formulary

  August 5, 2015

  Irvin Jackson

  Onglyza and several other drugs have been dropped from Express Scripts insurance coverage lists due to health concerns and the presence of safer, affordable alternatives.

• Hospitalization Risk from Onglyza Heart Failure Questioned in New Study

  August 3, 2015

  Irvin Jackson

  The findings of a new study claiming Onglyza does not cause heart failure are in contrast to findings by a panel of FDA experts who want new warnings placed on the drug.

• Health Problems Linked to Invokana, Farxiga, Onglyza, Nesina in Adverse Event Reports

  June 29, 2015

  Irvin Jackson

  Some diabetes drugs unexpected linked to heart failure risks, new report finds.

• HeartWare Ventricular Assist System Recall: Bent Pins Could Lead To Death

  June 17, 2015

  Russell Maas

  HeartWare is recalling hundreds of ventricular assist systems because connector pins can become bent, creating a risk of serious injury or death for patients.

• Another Study Highlights Link Between Digoxin and Death Risk

  June 2, 2015

  Irvin Jackson

  A new study finds that the heart drug digoxin can significantly increase the risk of death among heart patients, especially those suffering from atrial fibrillation.

• Left Ventricular Assist Devices (LVADs) Linked to Risk of Cognitive Problems: Study

  May 4, 2015

  Irvin Jackson

  A new study suggests that heart implants like the HeartMate II may cause a decline in mental functioning and memory in older patients.

• Onglyza Heart Failure Warnings Should Be Added, FDA Advisors Say

  April 16, 2015

  Irvin Jackson

  An FDA advisory committee is calling on the agency to add new warning labels to the diabetes drug Onglyza, including warnings of risks of heart failure and death.

• Onglyza Side Effects Increase Risk of Death, FDA Reviewers Warn

  April 13, 2015

  Austin Kirk

  FDA reviewers warn that the diabetes drug Onglyza may increase the risk of death in some patients.

• Onglyza Heart Problems Topic of Upcoming FDA Advisory Committee

  March 27, 2015

  Irvin Jackson

  An FDA advisory committee will look at data indicating potential Onglyza heart problems at a meeting in April.

• Benicar Drug Combo Increases Health Risks For Patients With Heart Failure: Study

  March 25, 2015

  Irvin Jackson

  Benicar combined with heart drugs failed to help patients suffering from both hypertension and heart failure, and increased their risk of death, strokes, and kidney problems, according to a recent study.